openPR Logo
Press release

Global Cell and Gene Therapy CDMO Market is projected to witness a CAGR of 25% to reach $5 billion by 2025 - Growing Cases of Cancer and Other Targeted Diseases

11-24-2022 12:41 PM CET | Health & Medicine

Press release from: Medi-Tech Insights

Global Cell and Gene Therapy CDMO Market is projected to witness

Robust CGT pipeline with an increasing number of product approvals, healthy support from large pharmaceutical and biotechnology companies and consistent investor enthusiasm (~$20 billion raised in 2020) is projected to boost the demand for CGT services. Growing pipeline of therapies are nearing regulatory decisions. Out of 1,220 ongoing clinical trials in 2020, 152 were in Phase 3 - FDA and EMA predict approval of 10-20 cell and gene therapies each year by 2025.

An Increasing Demand for Full-service/One-stop-shop CDMOs

Full-service CDMOs which can assist with both development and manufacturing are in high demand. Much of the Cell and Gene Therapy development as of late has been from smaller biotechnology companies or research universities who depend on CDMOs from preclinical development through packaging.

"There is a high demand for Cell and Gene Therapy CTDMOs who can offer integrated development, manufacturing, and testing services. For companies operating in CGTs, outsourcing manufacturing and testing operations to a capable CTDMO can reduce development timelines, provide supplementary capacity and ultimately reduce costs."-Senior Director, Tier 1 CGT CDMO, United States

Substantial Outsourcing in Cell and Gene Therapy Market due to Lack of Internal Capabilities

The current level of outsourcing in CGT market exceeds 60% which is far above the level of outsourcing seen in overall pharmaceutical and biologics segment. Cell & Gene Therapy is a complex segment requiring high level of domain expertise. Also, it has costly production and different manufacturing process/infrastructure requirements as compared to traditional small molecules. Big pharmaceutical companies currently lacks production-ready infrastructure and are increasingly looking for CGT CDMOs to enter or expand their presence in this rapidly growing CGT CDMO market. Moreover, growing influx of small biotech companies in the global market with limited/no manufacturing capabilities and/or with development expertise further provides ample growth opportunities for the Cell and Gene Therapy CDMO market.

Geographic Overview: North America is the Largest and Fastest Growing Market

North America is estimated to witness the fastest growth and continue its dominance in the coming 5 years owing to growing manufacturing capacity for CGTs, favorable regulatory approval process, growing CGT approvals per year, and strong product pipeline of CGTs in USA.

Competitive Landscape Analysis: Cell and Gene Therapy CDMO Market

The global Cell and Gene Therapy CDMO market is marked by the presence of both established players and several small and mid-sized players. Some of the major and leading players operating in the CGT CDMO market are Lonza, Catalent, Patheon, Wuxi Advanced Therapies and Charles River Laboratories. Other promising players in the market are Vive Biotech, SK Bioscience, Fujifilm, Vibalogics, Exothera, Takara, Oxford Biomedica, Viralgen and AGC Biologics, among several others.

Get Detailed Insights on Cell and Gene Therapy (CGT) CDMO Market with a Sample Report @

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Healthcare IT, MedTech, Medical Devices & Pharma Services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cell and Gene Therapy CDMO Market is projected to witness a CAGR of 25% to reach $5 billion by 2025 - Growing Cases of Cancer and Other Targeted Diseases here

News-ID: 2820130 • Views: 255

More Releases from Medi-Tech Insights

Global Medical Display Market is set to grow at a CAGR of ~5% by 2027 - Increasi …
Medical displays are purpose-built solutions which offers enhancements in viewing angle, longevity, luminance, and noise reduction to ensure substantially superior accuracy and effectiveness of medical images. Technological Innovations and Developments in Medical Display Triggers the Medical Display Market Growth With the rapid innovations of medical technology, more and more high-end medical equipments and medical devices is being introduced in the global market. Flat-panel displays, holograms, and head-mounted displays are rapidly changing the
Global Newborn Screening Market is set to grow at a 6-8% CAGR by 2027 - SCIEX, A …
Newborn screening aims to identify infants at risk of genetic, hormonal and metabolic medical conditions. These screens are used to confirm a diagnosis and allow for early intervention in the hope of prevention or amelioration of the disease. These tests are most commonly performed for conditions which are not evident in the neonatal period but are likely to be treatable with early intervention. Commonly covered medical conditions are congenital hypothyroidism, congenital
Global Fetal Monitoring Devices Market is set to grow at a CAGR of 5-7 % by 2027 …
Fetal monitoring devices are diagnostic tools often used to monitor the vital parameters of fetal throughout pregnancy, labor, and delivery. During the first trimester, it is mainly used for monitoring fetal heart rate and fetal movement. These systems help in identifying any disorders or birth defects, monitor fetal health, and track uterine contractions to ensure the safe birth of the baby. Despite a Slowdown for Fetal Monitoring Devices Owing to Covid-19,
Global Nerve Repair and Regeneration Market is set to grow at a 12% CAGR by 2027 …
Repair and regeneration in the nervous system is a process by which damaged tissue undergoes regrowth or renewal, eventually restoring nervous system function. Technological Innovations and Developments in Neurostimulation & Neuromodulation Devices Neurostimulation & Neuromodulation devices find their usage in many applications such as to treat traumatic or neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, sacral nerve stimulation for pelvic disorders and incontinence, and spinal cord

All 5 Releases

More Releases for CDMO

Global Packaging CDMO Market Is Witnessing a Sustainable Growth Due to Increase …
The latest release from WMR titled Packaging CDMO Market Research Report 2022-2028 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the Packaging CDMO including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles, and strategies. Global Packaging CDMO Market study with 100+ market data Tables, Pie Chat, Graphs & Figures is now released BY WMR. The report presents
Medical Robotics to Drive the CMO/CDMO Biotechnology Market
The CMO/CDMO Biotechnology Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. The global
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market …
Precision Business Insights published a research report on “Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market: By Service (Pharmaceutical Manufacturing Services, Drug Development Services and Biologics Manufacturing Services), By End User (Small & Mid-Size Pharma, Generic Pharmaceutical Companies, Big Pharma and Other End Users) and Geography - Global/Region/Country Forecast to 2028”. A contract development and manufacturing company (CDMO) is a corporation that provides drug development and manufacturing services to
The CMO/CDMO Biotechnology Market to elevate itself with digital transformation
The CMO/CDMO Biotechnology Market is ascertained to make greater strides in the future. The present-day and futuristic cutting-edge technology, namely IoT, AI, and Big Data operate better in a lightning-fast and reliable internet connection. The benefits of high-speed internet would be seen in telecare in the next 2-3 years, but going forward, more authentic data streams are likely to come up with better-connected devices, thereby revolutionizing the healthcare system. The global
Unprecedented, constructive disruption to drive the CMO/CDMO Biotechnology Marke …
The CMO/CDMO Biotechnology Market is slated to witness exponentiation going forward. The IoMT (Internet-of-Medical-Things) is already transforming every walk of life, including healthcare. Healthcare IT has let both - patients and doctors carry/download information about each other anywhere and anytime through their smartphones/tabs. In other words, more connectivity translates to better access to data, thereby rendering better healthcare for patients. This would be the future of the healthcare vertical in
Cosmetic CDMO and CMO Market 2021 | Detailed Report
According to Market Study Report, Cosmetic CDMO and CMO Market provides a comprehensive analysis of the Cosmetic CDMO and CMO Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Cosmetic CDMO and CMO Market @ The